Kolexia
Cognard Noelle
Néphrologie
Hôpital Civil
Strasbourg, France
62 Activités
6 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Maladies du rein Syndrome hémolytique et urémique Néphrocarcinome Fistule artérioveineuse Insuffisance rénale chronique Carcinomes Syndrome hémolytique et urémique atypique Fistule

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2022
Amicus Therapeutics
1 collaboration(s)
Dernière en 2023
Astellas
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Transplantation   20 juillet 2023
Use of tecovirimat for the treatment of mpox infection in a kidney transplant recipient.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   08 février 2023
Breast cancer and organ transplantation: Systematic review and meta-analysis.
Gynecologie, obstetrique, fertilite & senologie   11 novembre 2022
Updated National Study of Functional Graft Renal Cell Carcinomas: Are They a Different Entity?
Urology   12 octobre 2022
A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
Kidney international   13 août 2022
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
Journal of personalized medicine   05 juillet 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   30 juin 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Science translational medicine   16 mars 2022
High-flow arteriovenous fistula and hemodynamic consequences at 1 year after kidney transplantation.
Seminars in dialysis   02 novembre 2021
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.
Transplantation   11 octobre 2021